Rankings
▼
Calendar
FTRE Q4 2023 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena
FTRE
Fortrea Holdings Inc.
$851M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$775M
+54.3% YoY
Gross Profit
$120M
15.4% margin
Operating Income
-$11M
-1.4% margin
Net Income
-$36M
-4.6% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
+8.6%
Cash Flow
Operating Cash Flow
$12M
Free Cash Flow
$3M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$4.3B
Total Liabilities
$2.6B
Stockholders' Equity
$1.7B
Cash & Equivalents
$109M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$775M
$503M
+54.3%
Gross Profit
$120M
$284M
-57.9%
Operating Income
-$11M
-$8M
-28.9%
Net Income
-$36M
$27M
-234.8%
Revenue Segments
Clinical Services Segment
$1.4B
100%
Geographic Segments
North America
$814M
53%
Europe
$423M
27%
Other Geographical Areas
$303M
20%
← FY 2023
All Quarters
Q1 2024 →